ASBP — ASPIRE BIOPHARMA HLDGS INC

Ownership history in Platform Technology Partners  ·  4 quarters on record

This page tracks every 13F SEC filing in which Platform Technology Partners reported a position in ASPIRE BIOPHARMA HLDGS INC (ASBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q1)
Avg. % of fund
0.0%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 37,611 — 0% 0.00% $5K $5.28
2025 Q3 UNCHANGED 37,611 — 0% 0.00% $8K $8.24
2025 Q2 UNCHANGED 37,611 — 0% 0.00% $10K $10.76
2025 Q1 INITIATED 37,611 — — 0.01% $22K $23.32
% of Fund (quarterly)    ASBP price (monthly, adj. close)

Other funds also holding ASBP

As of 2025 Q4 — sorted by position size

Antara Capital LP 3Y 7Y 88.65% Optivise Advisory Services LLC 0.03% Crewe Advisors LLC 3Y 7Y 0.01% Resolute Advisors LLC 3Y 0.01% Scientech Research LLC 0.0% P SCHOENFELD ASSET MANAGEMENT LP 3Y 7Y 0.0% VR Advisory Services Ltd 3Y 7Y 0.0% Procyon Advisors, LLC 3Y 0.0% Avion Wealth 3Y 0.0% XTX Topco Ltd 3Y 0.0%
← Back to Platform Technology Partners Holdings